241 related articles for article (PubMed ID: 24879454)
1. Changing histopathological diagnostics by genome-based tumor classification.
Kloth M; Buettner R
Genes (Basel); 2014 May; 5(2):444-59. PubMed ID: 24879454
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathology of Gastric Cancer.
Kim M; Seo AN
J Gastric Cancer; 2022 Oct; 22(4):273-305. PubMed ID: 36316106
[TBL] [Abstract][Full Text] [Related]
3. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
4. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
[TBL] [Abstract][Full Text] [Related]
5. New horizons in bladder cancer research.
Boormans JL; Zwarthoff EC; Black PC; Goebell PJ; Kamat AM; Nawroth R; Seiler R; Williams SB; Schmitz-Dräger BJ
Urol Oncol; 2020 Dec; 38(12):867-885. PubMed ID: 30852032
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification of soft tissue sarcomas and its clinical applications.
Jain S; Xu R; Prieto VG; Lee P
Int J Clin Exp Pathol; 2010 Apr; 3(4):416-28. PubMed ID: 20490332
[TBL] [Abstract][Full Text] [Related]
7. On the Way to New Horizons: Telemedicine in Oncology.
Schlag PM
Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
[TBL] [Abstract][Full Text] [Related]
8. Translating cancer genomes sequencing revolution into surgical oncology practice.
Katsios C; Ziogas DE; Liakakos T; Zoras O; Roukos DH
J Surg Res; 2012 Apr; 173(2):365-9. PubMed ID: 21195428
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
10. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Cheng F; Hong H; Yang S; Wei Y
Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.
Shukla HD
Proteomes; 2017 Oct; 5(4):. PubMed ID: 29068423
[TBL] [Abstract][Full Text] [Related]
12. The breast cancer genome--a key for better oncology.
Vollan HK; Caldas C
BMC Cancer; 2011 Nov; 11():501. PubMed ID: 22128823
[TBL] [Abstract][Full Text] [Related]
13. Genetic and molecular markers of urothelial premalignancy and malignancy.
Cordon-Cardo C; Cote RJ; Sauter G
Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
[TBL] [Abstract][Full Text] [Related]
14. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment.
Funakoshi Y; Hata N; Kuga D; Hatae R; Sangatsuda Y; Fujioka Y; Takigawa K; Mizoguchi M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673070
[TBL] [Abstract][Full Text] [Related]
16. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
17. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
Wirsching HG; Weller M
Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
[TBL] [Abstract][Full Text] [Related]
18. Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach.
Blanco-Calvo M; Concha Á; Figueroa A; Garrido F; Valladares-Ayerbes M
Int J Mol Sci; 2015 Jun; 16(6):13610-32. PubMed ID: 26084042
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
